Crestor, containing rosuvastatin, is a widely prescribed statin medication for managing cholesterol levels. It lowers LDL (bad cholesterol) and triglycerides while raising HDL (good cholesterol), reducing the risk of cardiovascular complications such as heart attacks and strokes. It is a trusted choice for individuals at risk of heart disease or those with high cholesterol.
Benefits of Crestor:
Dosage:
Warnings and Precautions:
Usage Instructions:
Storage Information:
Common Side Effects:
More information about Crestor:
See also:CRESTOR 40MG TABLET is used in the management of high blood cholesterol levels. It is prescribed when diet and exercise does not result in adequate results. It contains a medicine called which is an anti-hyperlipidemic agent that works by blocking cholesterol production in the body. It also makes your body eliminate lipids particles from the blood.
By reducing blood cholesterol levels, this medicine is helpful is reducing cardiovascular risks and problems in blood circulation across the body. While taking CRESTOR 40MG TABLET, you must follow a cholesterol-lowering diet, lifestyle changes and regular physical activity as instructed by your doctor to achieve better results.
Before taking CRESTOR 40MG TABLET inform your doctor if you have any lung, liver, kidney or heart problems. You must also inform your doctor if you have diabetes, thyroid problems, or a family history of muscle disorders. Do not take CRESTOR 40MG TABLET if you are pregnant or breastfeeding without consulting your doctor.
CRESTOR 40MG TABLET may increase your blood sugar levels, especially in patients who are diabetic. It may also affect the way your liver works and so your doctor will closely monitor your blood sugar levels and liver functions while undergoing therapy with CRESTOR 40MG TABLET as a precaution.
The most common side effects of taking CRESTOR 40MG TABLET are muscle ache, constipation, stomach pain, dizziness, nausea and headache. Inform your doctor if you experience severe unexplained muscle pain, tenderness or weakness along with fever after taking CRESTOR 40MG TABLET.
Yuejin Guanyan Zhao family doctor ialah valtrexBefore taking CRESTOR 40MG TABLET, tell your doctor about all other approved fertility treatments you are taking, such as Ferturative fonction intra-abdominal (FFC-IA) treatment for ovum preparation (FERTURBEE) or Ferturative alfuzosin for recurrent idiopathic oligo-ethenes (ERO) (FERTURBEE) onlfreezia (FERTURFZOI) (2019-2022). Your doctor may issue you with a prescription containinginfo generic 5-alpha-reductase inhibitors (5-ARI).
CRESTOR 40MG TABLET may cause a drop in blood pressure, especially when taken at the same time each day. This can lead to dizziness, fainting, seizures and possible heart attack in people who are also taking benzodiazepines, such as diazepam (PBAZ), zaz peddled to treat anxiety. Tell your doctor if you have preexisting medical conditions such as heart, liver or kidney disease.
In some cases, CRESTOR 40MG TABLET may cause blurred vision, or other effects such as increased muscle mass or discomfort. If you experience any other effects or allergic reactions, contact your doctor immediately.
The most common side effects of taking CRESTOR 40MG TABLET include headache, nausea, diarrhea, loss of appetite, decreased libido, orgasmic discomfort, rash, sweating, itching, and a stuffy nose in some people. However, most of these side effects do not require medical attention and will resolve gradually in the future. However, if the side effects persist or worsen, contact your doctor.
It is important to avoid taking CRESTOR 40MG TABLET if you are pregnant or breastfeeding without consulting your doctor. The medicine may cause fetal abnormalities, so you must consult your doctor if you think you are having problems with your pregnancy.
A new trial of statins is being conducted at the University of North Carolina (UNC), in Chapel Hill, to determine the most effective and safest treatment of type 2 diabetes in adults and their children. The study was done by using a combination of blood-thinning agents including glyburide, simvastatin, rosuvastatin, and atorvastatin to reduce the risk of death in adults with type 2 diabetes.
The findings of the study, published in the November 2017 issue of theNew England Journal of Medicine, are part of the.
According to the.
“The results of the new trial indicate that, when administered in combination, rosuvastatin and glyburide may be the most effective approach for lowering the risk of death in adults with type 2 diabetes,” Dr. Michael Pearson, a cardiologist at the UNC School of Medicine, told.
“We are very concerned about this combination of drugs and this is an important clinical trial to be conducted to determine the optimal treatment.”
The study has been led by Dr. Richard M. Rosenbaum of the University of North Carolina. It was presented at the American Diabetes Association's annual meeting, held in October, 2017.
“It's been very well received by the medical community, which we hope will be the next major study to be conducted at the University of North Carolina,” said Dr. Rosenbaum.
“It's a great opportunity to see the results of a large study that we have been doing.”
The study was led by Dr. Michael Pearson, M. D., of the University of North Carolina. The trial is funded by the National Institutes of Health (NIH).
The most recent results of the study were published in May 2014 by the
“We were very excited to get the results of this study and we are so pleased to be able to participate in it,” said Dr. Michael Pearson.
According to the, the study showed that people with type 2 diabetes were less likely to have a heart attack or a stroke than people without diabetes, and their risk of having one was reduced by 15% for those with type 2 diabetes.
In addition, the study showed that the use of statins in combination with other drugs, including atorvastatin, rosuvastatin, and lovastatin, increased the risk of heart attack, stroke, and death.
“This is an important clinical trial to be conducted to determine the optimal treatment for type 2 diabetes,” said Dr. M. J. Ransdorf, professor of medicine, and chair of the department of cardiology at UNC.
The new study was also led by Dr. Richard Rosenbaum, M. D., associate professor of medicine, and director of the at-risk cardiology department at UNC.
According to the, people with type 2 diabetes were less likely to have a heart attack or a stroke than people without diabetes, and their risk of having one was reduced by 15% for those with type 2 diabetes.
The study was conducted with the U. S. Food and Drug Administration (FDA) for use in combination with rosuvastatin and atorvastatin in patients with type 2 diabetes. The combination is known as rosuvastatin-simvastatin (Crestor®).
“We know that in people with type 2 diabetes, there are two potential risk factors that are important for developing type 2 diabetes,” said Dr. “The first is a higher incidence of cardiovascular disease, such as heart attack or stroke, with this combination, and the second is the risk of being diagnosed with diabetes in those who are at an increased risk of developing cardiovascular disease.”
“We are pleased to be able to continue to bring this important clinical trial to the attention of the medical community and help reduce the risk of heart attack, stroke, and death in people with type 2 diabetes,” said Dr. Pearson.
“The new study provides an important new indication for this combination of drugs and is an important clinical trial to be conducted to determine the optimal treatment for type 2 diabetes,” said Dr. Richard Rosenbaum.
About the New England Journal of Medicine
The National Institutes of Health approved the new study of the study.
The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.
Nurofen Tablets, 60 Capsules(NUROFEN, 60)
Product SpecificationsWeight Loss Tablets (Nurofen, 60 Capsules)
Active Ingredients, 60 Capsules:Nurofen Tablet
Nurofen, 60 Capsules
Manufacturer,AstraZenecaTeva PharmaceuticalsNovartis Pharma AG
Eli Lilly and Co.
Indications,Adults and Children:Erythema Bullis, Acne and Skin
Dosage & AdministrationTake with water. Adults and Children 12 years and over:
Swallow the tablet whole with water. If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, take it as soon as it has become time. Do not take 2 doses at the same time. Swallow the tablet whole with enough water. Do not chew or crush the tablet. Do not take this medicine after the full prescribed amount. CRESTOR 5MG Tablets, 60 Capsules, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat inflammation and pain in the body. It works by stopping the production of prostaglandins, which is important for pain signals from the stomach and brain. CRESTOR 5MG Tablets, 60 Capsules, can reduce the pain and inflammation caused by certain types of arthritis, while the generic reliever medicine is the same as the brand-name product. The differences between the brand-name and generic CRESTOR 5MG Tablets, 60 Capsules, make them less expensive and easier to use. Take CRESTOR 5MG Tablets, 60 Capsules, with a meal to avoid. CRESTOR 5MG Tablets, 60 Capsules, can also be used for purposes not listed in this medication guide.
Zhou HuiNurofen Tablets, 60 Capsules, is a prescription medication used to treat:
Adjunct pain relief
Do not crush or chew the tablet.
Treatment of arthritis
Erectile dysfunction
Liver function tests
Blood counts
Erectile dysfunction treatment
Renal function tests
Sexual function tests
Clomiphene citrate (Clomid) injection for infertility
Adults:Erythema, Acne, Skin
Generic name: Rosuvastatin
Rosuvastatin calcium
Centurion Laboratories Ltd.
Treatment of hypercholesterolemia (high cholesterol levels in the blood)
In the treatment of atherosclerosis (hardening of the arteries)
In patients with severe cardiovascular disease. Rosuvastatin is a once-daily oral tablet, taken by mouth. The tablet should be taken once daily, at a dose of 5 mg once daily with a meal, preferably within the first 6 hours of the dose, and not more than once every 8 hours.
Dizziness, headache, and flushing may occur. These may be mild and transient.
Allergy may be reported.
Other side effects include:
Not to be used in pregnant or nursing women.
Stade de France Pharmacy